Agent for improving insulin resistance
AssigneeMorinaga Milk Industry Co., Ltd.
InventorsMiyuki Tanaka, Eriko Misawa
Life of this patent
Estimating the term…
Abstract
To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient.
Claims2
A method for treating hyperinsulinemia or abnormal glucose tolerance, which comprises administering an ethyl acetate/butanol mixture (3:1) extract or a chloroform/methanol mixture (2:1) extract of mesophyll of Aloe vera (Aloe barbadensis Miller), or a fraction thereof, which comprises at least 0.001% by mass of a compound selected from the group consisting of 4-methyl-cholest-7-en-3-ol, 4-methyl-ergost-7-en-3-ol, and 4-methyl-stigmast-7-en-3-ol, to a subject whose hyperinsulinemia or abnormal glucose tolerance is to be treated.
A method for treating hyperinsulinemia or abnormal glucose tolerance, which comprises administering at least 0.001% by mass of a compound selected from the group consisting of 4-methyl-cholest-7-en-3-ol, 4-methyl-ergost-7-en-3-ol, and 4-methyl-stigmast-7-en-3-ol, to a subject whose hyperinsulinemia or abnormal glucose tolerance is to be treated.
Dependencies are inferred from the claim text.